David Steinberg has served as a member of our board of directors since March 2017. Mr. Steinberg is currently a general partner at Longwood Fund, which he joined in September 2018. Mr. Steinberg is a co-founder of PureTech Health plc (PRTC.L) and served as the Chief Innovation Officer from September 2002 through August 2018. As a senior executive officer of PureTech Health, Mr. Steinberg was involved in initiating and leading multiple PureTech Health programs, including PureTech Health’s microbiome initiative, lymphatic biology platform and immune-oncology pipeline. Previously, Mr. Steinberg was a strategy consultant with the Boston Consulting Group and Vertex Partners, focusing on R&D and product strategy and strategic alliances for Fortune 500 pharmaceutical and biotechnology clients. Mr. Steinberg is also a member of the University of Chicago Tech Innovation Fund Advisory Committee. Mr. Steinberg is the founder and former Chief Executive Officer of Pyxis Oncology, Inc. and currently serves on its board of directors. He received his B.A. in Biology with distinction from Cornell University and graduated with high honors from the University of Chicago Booth School of Business with an M.B.A. in Strategy and Finance.